The DOJ’s Antitrust Division is returning to targeted Second Request investigations.
Regulation
Regulator urges firms experiencing growth to consider findings and assess whether arrangements remain appropriate.
Our regular roundup of the latest news and developments from the FCA.
FDA sets FY 2027 medical device user fees, updating submission and registration costs under MDUFA V and outlining small business reductions.
Two FCA consultation papers prepare for implementation of an equities CT in the UK and aim to improve accessibility and clarity of trade data.
A new study found proposed Medicare drug pricing models may rely on prices from relatively few international markets.
Centers for Medicare & Medicaid Services moves to strengthen oversight of Applied Behavior Analysis services and reduce fraud, waste, and abuse.
HRSA health centers deliver ‘record-breaking’ care to 32.7 million patients
Quick Read
Premium
HRSA health centers are driving prevention first care, expanding access in underserved communities, and reinforcing accountability across the nation’s primary care system.